Genotype-guided switch from ravulizumab to satralizumab in aquaporin-4–IgG–positive neuromyelitis optica spectrum disorder: a case of C5 polymorphism-associated ravulizumab resistance
本文未提供摘要，请点击“查看全文”查看完整内容。